Skip to main content
SpringerLink
Log in

Predicting Response to Chronic Antihypertensive Treatment with Fosinopril: The Role of Angiotensin-Converting Enzyme Gene Polymorphism

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Insertion (I)/deletion (D) polymorphism of the ACE gene has been reported to be involved in various cardiovascular diseases. We investigated prospectively whether the response to the ACE inhibitor fosinopril varied according to the ACE genotype in previously untreated Greek hypertensive patients. After a 4-week observation period, fosinopril was administered at a dose of 20 mg daily and blood pressure was measured weekly for 6 months. The study population consisted of 104 hypertensive patients (46 male, 58 female). There were no differences in age, gender, body mass index, and pretreatment blood pressure levels among patients with the DD, ID, and II genotypes (n = 42, 30, 32, respectively). The reduction in systolic blood pressure was significantly greater in patients carrying the DD compared to II or ID genotypes (5.6 ± 3.1 vs. 3.1 ± 1.1 or 3.6 ± 2.2, respectively; ANOVA, p < 0.05). The reduction in diastolic blood pressure was also significantly greater in DD hypertensives compared with II or ID (8.9 ± 6 vs. 5.5 ± 3.4 or 5.8 ± 4, respectively; ANOVA, p < 0.05). The age and BMI were not correlated with the changes in SBP or DBP that were observed after fosinopril administration. In conclusion, the ACE gene genotype was shown to influence the response to fosinopril in hypertensive patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the co-operative North Scandinavian Enalapril Survival Study. N Engl J Med 1987;316:1429-1435.

    Google Scholar 

  2. Dahlof B, Pennert K, Hannson L. Reversal of left ventricular hypertrophy in hypertensive patients. A meta-analysis of 109 treatment studies. Am J Hypertens 1992;5:95-110.

    Google Scholar 

  3. Donnely R, Meredith PA, Elliot HL. The description and prediction of antihypertensive drug response. Br J Clin Pharmacol 1991;31:627-634.

    Google Scholar 

  4. Postma C, Dennesen P, De Boo T, Thien T. First dose hypotension after captopril; can it be predicted? A study of 240 patients. J Hum Hypertens 1992;6:205-209.

    Google Scholar 

  5. Cody RJ, Laragh JH, Case DB, Atlas SA. Renin system activity as a determinant of response to treatment in hypertension and heart failure. Hypertension 1983;5(Suppl III):36-42.

    Google Scholar 

  6. Opie LH. Angiotensin Converting Enzyme Inhibitors. New York: Wiley-Liss, 1992:24-26.

    Google Scholar 

  7. Donnely R, Meredith PA, Elliot HL, Reid JL. Kinetic-dynamic relations and individual responses to enalapril. Hypertension 1990;15:301-309.

    Google Scholar 

  8. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. ACE in human circulation mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993;290:33-40.

    Google Scholar 

  9. Danser AH, Schalekamp AD, Bax WA, et al. ACE in the human heart. Circulation 1995;92:1387-1388.

    Google Scholar 

  10. CambienF, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting-enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644.

    Google Scholar 

  11. Heribert S, Hans Wemer H, Stephen RH, et al. Association between a deletion polymorphism of the ACE gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-1638.

    Google Scholar 

  12. Tiret L, Blanc H, Ruidavets JB, et al. Gene polymorphisms of the renin-angiotensin-system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet d'Etude des Genes de l' Hypertension Arterielle Severe a Moderee Essentielle. J Hypertens 1998;16:37-44.

    Google Scholar 

  13. Ueda S, Meredith PA, Morton JJ, Connell JMC, Elliot HL. ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans. Circulation 1998;98:2148-2153.

    Google Scholar 

  14. Nakano V, Oshima T, Watanabe M, Matsuura H, Kajiyama G, Kambe M. ACE gene polymorphism and acute response to captopril in essential hypertension. Am J Hypertens 1997;10:1064-1068.

    Google Scholar 

  15. The Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The fifth report of the JNC. Arch Intern Med 1993;153:154-183.

    Google Scholar 

  16. Sedell JC, Cigolini M, Deslypere JP, Charzewska J, Elisinger B, Cruz B. Body fat distribution in relation to physical activity and smoking habits in 38 year old European men. Am J Epidemiol 1991;133:257-265.

    Google Scholar 

  17. Tiret L, Rigat B, Visvikis S, et al. Evidence from combined segregation and linkage analysis that a variant of the ACE gene controls plasma levels. Am J Hum Genet 1992;1:197-205.

    Google Scholar 

  18. Shaumugan V, Sell KW, Saha BK. Misstyping ACE heterozygotes. PCR Methods Appl 1993;3:120-121.

    Google Scholar 

  19. Mondorf U, Russ A, Wiesemann A, Herrero M, OremeK G, Lenz T. Contribution of ACE gene polymorphism and angiotensinogen gene polymorphism to blood pressure reduction in essential hypertension. Am J Hypertens 1998;11:174-183.

    Google Scholar 

  20. Juillerat L, Nussberger J, Menard J, et al. Determinants of angiotensin II generation during ACE inhibition. Hypertension 1990;16:564-572.

    Google Scholar 

  21. Bidiville J, Nussberger J, Waeber G, Porchet M, Waeber B, Brunner HR. Individual responses to ACE inhibitors and calcium antagonists. Hypertension 1988;11:166-173.

    Google Scholar 

  22. Laragh JH, Case DB, Atlas SA, Sealey JA. Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor. Hypertension 1980;2:586-593.

    Google Scholar 

  23. Brunner HR, Waeber B, Nussberger J, Schaller MD, Gomez HJ. Long term clinical experience with enalapril in essential hypertension. J Hypertens 1983;1(Suppl 1):103-107.

    Google Scholar 

  24. Van den Meiracker AH, Man in't Veld AJ, Admiraal PJ, et al. Partial escape of ACE inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response? J. Hypertens 1992;10:803-812.

    Google Scholar 

  25. Benetos A, Gavras H, Stewart JM, Vavrek RJ, Gavras I. Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist. Hypertension 1983;8:971-974.

    Google Scholar 

  26. Petretta M, Bonaduce D, Marciano F, et al. Effect of 1 year of lisinopril treatment on cardiac autonomic control in hypertensive patients with left ventricular hypertrophy. Hypertension 1996;27:330-338.

    Google Scholar 

  27. Chaignon M, Barrou Z, Ayad M, et al. Effects of perindopril on renal haemodynamics and natriuresis in essential hypertension. J Hypertens 1988;6(Suppl 3):S1-S64.

    Google Scholar 

  28. Levy BI, Michel JB, Salzmann JL, et al. Long term effect of ACE inhibition on the arterial wall of adult spontaneously hypertensive rats. Am J Cardiol 1993;71:8E-16E.

    Google Scholar 

  29. Gohlke P, Lamberty V, Kuwer I, et al. Vascular remodelling in systemic hypertension. Am J Cardiol 1993;7:2E-7E.

    Google Scholar 

  30. Dzau VJ. Vascular renin-angiotensin-system and vascular protection. J Cardiovasc Pharmacol 1993;22(Suppl 5):S1-S9.

    Google Scholar 

  31. Malic FS, Lavie CJ, Mehra MR, Milani RV, Re RN. Renin-angiotensin-system: Genes to bedside. Am Heart J 1997;134:514-526.

    Google Scholar 

  32. Perticone F, Cevalolo R, Maio R, et al. ACE gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients. Hypertension 1998;31:900-905.

    Google Scholar 

  33. Kario K, Matsuo T, Kobayashi H, et al. Endothelial cell damage and ACE l/D genotype in elderly hypertensive patients. J Am Coll Cardiol 1998;32:444-450.

    Google Scholar 

  34. Unkelbach M, Auch Schwelk W, Unkelbach E, Jautzke G, Fleck E. Regulation of aortic wall structure by the renin angiotensin system in Wistar rats. J Cardiovasc Pharmacol 1998;31:31-39.

    Google Scholar 

  35. Rizzoni D, Castellano M, Porteni E, et al. Prolonged effects of fosinopril on blood pressure and vascular morphology and function in rats. Am J Hypertens 1997;10:1034-1043.

    Google Scholar 

  36. Olbrich A, Rosen P, Hilgers RB, Dheim S. Fosinopril improves regulation of vascular tone in mesenteric bed of diabetic rats. J Cardiovasc Pharmacol 1996;27:187-194.

    Google Scholar 

  37. Fernandez Lama P, Poch E, Oriola J, et al. Ace gene l/D polymorphism in essential hypertension and nephroangiosclerosis. Kidney Int 1998;53:1743-1747.

    Google Scholar 

  38. Shionoiri H, Navuse M, Minamisawa K, et al. Fosinopril clinical pharmacokinetics and clinical potential. Clin Pharmacokinet 1007;32:460-480.

  39. Sasaki M, Oki T, Iuchi A, et al. Relationship between the ACE gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies. J Hypertens 1996;14:1403-1408.

    Google Scholar 

  40. Dudley C, Kearney B, Casadei B, Conway J, Bird R, Ratcliffe P. Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of renin-angiotensin-system genes. J Hypertens 1996;14:259-262.

    Google Scholar 

  41. Ohmichi N, Iwai N, Uchida Y, et al. Relationship between the response to the ACE inhibitor and the ACE genotype. Am J Hypertens 1997;10:951-955.

    Google Scholar 

  42. Schunkert H, Hense HW, Brockel U, et al. Differential effects of antihypertensive drugs on neurohormonal activation: Insights from a population based sample. J Int Med 1998;244:109-119.

    Google Scholar 

  43. Schunkert H, Ingelfinger J, Hirsch A, et al. Feedback regulation of ACE activity and mRNA levels by angiotensin II. Circ Res 1993;72:312-318.

    Google Scholar 

  44. Fyhrquist F, Gronhagen Riska C, Hortling L, Forslund T, Tikkanen I. Regulation of ACE. J Hypertens 1983;1(Suppl):25-30.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, 2, Athens University Medical School, Athens, Greece

    George A. Stavroulakis, Thomas K. Makris, Panagiota G. Krespi, Antonios N. Hatzizacharias, Argyri E. Gialeraki, George Anastasiadis, Philippos Triposkiadis & Michael Kyriakidis

  2. Haemostasis Lab, “LAIKON” General Hospital, Athens, Greece

    George A. Stavroulakis, Thomas K. Makris, Panagiota G. Krespi, Antonios N. Hatzizacharias, Argyri E. Gialeraki, George Anastasiadis, Philippos Triposkiadis & Michael Kyriakidis

Authors
  1. George A. Stavroulakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas K. Makris
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Panagiota G. Krespi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antonios N. Hatzizacharias
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Argyri E. Gialeraki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. George Anastasiadis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Philippos Triposkiadis
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Michael Kyriakidis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stavroulakis, G.A., Makris, T.K., Krespi, P.G. et al. Predicting Response to Chronic Antihypertensive Treatment with Fosinopril: The Role of Angiotensin-Converting Enzyme Gene Polymorphism. Cardiovasc Drugs Ther 14, 427–432 (2000). https://doi.org/10.1023/A:1007820401377

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007820401377

Search

Navigation